Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
2.
Hum Mol Genet ; 9(2): 237-47, 2000 Jan 22.
Article in English | MEDLINE | ID: mdl-10607834

ABSTRACT

Neurofibromatosis type 1 (NF1) is one of the most common inherited disorders in humans and is caused by mutations in the NF1 gene. To date, the majority of the reported NF1 mutations are predicted to result in protein truncation, but very few studies have correlated the causative NF1 mutation with its effect at the mRNA level. We have applied a whole NF1 cDNA screening methodology to the study of 80 unrelated NF1 patients and have identified 44 different mutations, 32 being novel, in 52 of these patients. Mutations were detected in 87% of the familial cases, but in 51% of the sporadic ones. At least 15 of the 80 NF1 patients (19%) had recurrent mutations. The study shows that in 50% of the patients in whom the mutations were identified, these resulted in splicing alterations. Most of the splicing mutations did not involve the conserved AG/GT dinucleotides of the splice sites. One frameshift, two nonsense and two missense mutations were also responsible for alterations in mRNA splicing. The location and type of mutation within the NF1 gene, and its putative effect at the protein level, do not indicate any relationship to any specific clinical feature of NF1. The high proportion of aberrant spliced transcripts detected in NF1 patients stresses the importance of studying mutations at both the genomic and RNA level. It is possible that part of the clinical variability in NF1 could be due to mutations affecting mRNA splicing, which is the most common molecular defect in NF1.


Subject(s)
Genes, Neurofibromatosis 1 , Mutation/genetics , Neurofibromatosis 1/genetics , RNA Splicing/genetics , Adult , Aged , Child , Female , Genotype , Heteroduplex Analysis , Humans , Intellectual Disability/genetics , Male , Middle Aged , Neurofibroma, Plexiform/genetics , Optic Nerve Glioma/genetics , Pedigree , Phenotype , Polymorphism, Single-Stranded Conformational
3.
Prenat Diagn ; 19(8): 739-42, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10451518

ABSTRACT

Neurofibromatosis type 1 (NF1) is one of the most common genetic disorders in humans with an incidence of 1 in 3500. Most of the NF1 mutations reported so far (over 240 mutations) are unique. Specific prenatal diagnosis can only be provided to familial cases by an indirect linkage analysis or to families with a previously identified mutation. Here we report the first prenatal diagnosis in sporadic NF1 by direct characterization of the mutation. We first identified the skipping of exon 10b of NF1 in the mRNA from a woman affected by NF1 and without familial history of the disease. The analysis of genomic DNA identified mutation IVS10b+1G-->A as the cause of the skipping of exon 10b. Chorionic villus sampling (CVS) was performed at 10 weeks of gestation and total RNA was directly extracted from the sample. After reverse transcription (RT) and polymerase chain reaction (PCR) of the cDNA, the skipping of exon 10b was not identified in the CVS upon agarose gel electrophoresis. The fetal origin of the CVS was confirmed via polymorphic markers and the absence of the IVS10b+1G-->A mutation was confirmed by genomic analysis.


Subject(s)
Chorionic Villi Sampling , Genes, Neurofibromatosis 1 , Neurofibromatosis 1/diagnosis , Neurofibromatosis 1/genetics , Adult , DNA/analysis , Female , Fetal Diseases/diagnosis , Fetal Diseases/genetics , Humans , Mutation , Pregnancy , Pregnancy Trimester, First , RNA/analysis , Reverse Transcriptase Polymerase Chain Reaction , Trans-Splicing
4.
Am J Hum Genet ; 62(4): 834-41, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9529361

ABSTRACT

Spinal neurofibromatosis (SNF) has been considered to be an alternative form of neurofibromatosis in which spinal cord tumors are the main clinical characteristic. Familial SNF has been reported, elsewhere, in three families-two linked to markers within the gene for neurofibromatosis type 1 (NF1) and the other not linked to NF1-but no molecular alterations have been described in these families. We describe a three-generation family that includes five members affected by SNF. All the affected members presented multiple spinal neurofibromas and café au lait spots, one member had cutaneous neurofibromas, and some members had other signs of NF1. Genetic analysis, performed with markers within and flanking the NF1 gene, showed segregation with the NF1 locus. Mutation analysis, performed with the protein-truncation test and SSCP/heteroduplex analysis of the whole coding region of the NF1 gene, identified a frameshift mutation (8042insA) in exon 46, which should result in a truncated NF1 protein. The 8042insA mutation was detected in all five family members with the SNF/NF1 phenotype. To our knowledge, this is the first time that a mutation in the NF1 gene has been associated with SNF. The clinical homogeneity in the severity of the disease among the affected members of the family, which is unusual in NF1, suggests that a particular property of the NF1 mutation described here, a gene closely linked to NF1, or posttranscriptional events are involved in this severe neurological phenotype.


Subject(s)
Frameshift Mutation , Neurofibromatosis 1/genetics , Proteins/genetics , Adult , Child , DNA Mutational Analysis , Female , Humans , Male , Middle Aged , Neurofibromatosis 1/physiopathology , Neurofibromin 1 , Pedigree , Spinal Cord/physiopathology
5.
Am J Hum Genet ; 61(3): 512-9, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9326316

ABSTRACT

Neurofibroma is a benign tumor that arises from small or large nerves. This neoplastic lesion is a common feature of neurofibromatosis type 1 (NF1), one of the most common autosomal dominant disorders. The NF1 gene codes for a protein called "neurofibromin." It possesses a region that shares a high homology with the family of GTPase-activating proteins, which are negative regulators of RAS function and thereby control cell growth and differentiation. The evidence points to the NF1 gene being a tumor-suppressor gene. NF1 patients also have an increased incidence of certain malignant tumors that are believed to follow the "two hit" hypothesis, with one allele constitutionally inactivated and the other somatically mutated. Recently, somatic loss of heterozygosity (LOH) has been described for neurofibromas, and mutations in both copies of the NF1 gene have been reported for a dermal neurofibroma. The aim of our study was the analysis of the NF1 locus in benign neurofibromas in NF1 patients. We performed LOH analysis on 60 neurofibromas belonging to 17 patients, 9 of them with family history of the disease and 8 of them sporadic. We have analyzed five intragenic NF1 markers and six extragenic markers, and we have found LOH in 25% of the neurofibromas (corresponding to 53% of the patients). In addition, we found that in the neurofibromas of patients from familial cases the deletions occurred in the allele that is not transmitted with the disease, indicating that both copies of the NF1 gene were inactivated in these tumors. Therefore, the recent reports mentioned above, together with our findings, strongly support the double inactivation of the NF1 gene in benign neurofibromas.


Subject(s)
Genes, Neurofibromatosis 1/genetics , Mutation , Neurofibromatosis 1/genetics , Alleles , Chromosomes, Human, Pair 17/genetics , Female , Genetic Markers , Humans , Male , Neurofibromatosis 1/pathology , Pedigree , Sequence Deletion
6.
Hum Genet ; 98(6): 696-9, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8931703

ABSTRACT

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with a prevalence of around 1 in 3500, affecting all ethnic groups. The clinical manifestations of the disease are variable, even among members of the same family, and affect a variety of tissues and cell types, including skin, iris, central and peripheral nervous systems and skeletal system. It has been reported that the majority of sporadic mutations in NF1 arise in paternally inherited alleles. We present here a collaborative study of the parental origin and type of mutation in individuals with de novo NF1, who account for up to a half of all cases of clinically diagnosed NF1. We have studied intragenic and extragenic markers in 470 NF1 families. In 32 of these families it was possible to assess the parental origin of a de novo NF1 mutation either by linkage analysis (in families with three generations) or by the detection of an intragenic deletion in a sporadic NF1 case. Eleven of these 32 families have three generations (the second and third generation being affected), with the mutation (not a large deletion) being of paternal origin in 82% of them (P < 0.05). In the other 21 families an intragenic deletion was detected, in 76% being in the maternal chromosome and in 24% in the paternal one (P < 0.05). Our results suggest that in NF1 the majority of deletions occur in oogenesis, while other types of mutations should account for the paternally derived NF1 mutations.


Subject(s)
DNA Mutational Analysis , Genes, Neurofibromatosis 1/genetics , Sex Characteristics , Chromosome Mapping , Female , Humans , Male , Polymorphism, Restriction Fragment Length
7.
An Esp Pediatr ; 44(3): 250-6, 1996 Mar.
Article in Spanish | MEDLINE | ID: mdl-8830601

ABSTRACT

The objective of this study was to analyze clinically, cytogenetically and molecularly 85 Spanish families with fragile X syndrome. Clinical studies were based on the score proposed by Hagerman, cytogenetic studies were made by adding. 5-fluorodeoxiuridine and molecular studies were performed by using a StB12.3 probe and the polymerase chain reaction (PCR). The results of the molecular studies in 620 individuals at risk confirmed the clinical diagnosis of fragile X syndrome in 126 affected males. In addition, 197 carrier females were detected (48 with mental retardation) and 246 "at risk" individuals and 36 non-related members were found not to have the expansion. Fifteen cases of normal transmitting males (NTM) were detected. We found one non-mentally retarded male where the CpG island of the FMR-1 gene was not methylated, but with more than 200 (CGG)n repeats (high functioning male). In the sample studied, no de novo mutations were found and all of the mutations detected were (CGG)n expansions. PCR analysis of the (CGG)n repeat in 297 normal chromosomes showed an allele distribution that ranged from 17 to 54 repeats, with an allele of 29 (CGG)n repeats accounting for 24% of the chromosomes. In conclusion, molecular genetic study of fragile X provides accurate diagnosis and facilitates genetic counselling in families with affected members. Southern blot analysis and PCR of the (CGG)n repeat provides efficient diagnosis, compared to cytogenetic techniques, for the detection of female carriers, NTMs, and prenatal diagnosis.


Subject(s)
Fragile X Syndrome/genetics , Alleles , Base Sequence , DNA/genetics , DNA Probes , Female , Fragile X Syndrome/diagnosis , Heterozygote , Humans , Male , Molecular Sequence Data , Polymerase Chain Reaction/methods , Repetitive Sequences, Nucleic Acid/genetics , Risk Factors , Spain
8.
Am J Hum Genet ; 57(5): 1044-9, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7485153

ABSTRACT

Neurofibromatosis type 1 (NF1) is caused by deletions, insertions, translocations, and point mutations in the NF1 gene, which spans 350 kb on the long arm of human chromosome 17. Although several point mutations have been described, large molecular abnormalities have rarely been characterized in detail. We describe here the molecular breakpoints of a 12-kb deletion of the NF1 gene, which is responsible for the NF1 phenotype in a kindred with two children affected because of germline mosaicism in the unaffected father, who has the mutation in 10% of his spermatozoa. The mutation spans introns 31-39, removing 12,021 nt and inserting 30 bp, of which 19 bp are a direct repetition of a sequence located in intron 31, just 4 bp before the 5' breakpoint. The 5' and 3' breakpoints contain the sequence TATTTTA, which could be involved in the generation of the deletion. The most plausible explanation for the mechanism involved in the generation of this 12-kb deletion is homologous/nonhomologous recombination. Since sperm of the father does not contain the corresponding insertion of the 12-kb deleted sequence, this deletion could have occurred within the NF1 chromosome through loop formation. RNA from lymphocytes of one of the NF1 patients showed similar levels of the mutated and normal transcripts, suggesting that the NF1-mRNA from mutations causing frame shifts of the reading frame or stop codons in this gene is not degraded during its processing. The mutation was not detected in fresh lymphocytes from the unaffected father by PCR analysis, supporting the case for true germ-line mosaicism.


Subject(s)
Gene Deletion , Mosaicism , Neurofibromatosis 1/genetics , Proteins/genetics , Adolescent , Adult , Base Sequence , Chromosome Mapping , Female , Humans , Male , Molecular Sequence Data , Neurofibromin 1 , Pedigree , Polymerase Chain Reaction
9.
Hum Genet ; 96(3): 361-3, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7649559

ABSTRACT

We present two further cases of mutation R1947X in the neurofibromatosis type 1 gene. To date, a total of nine cases of mutation R1947X have been reported giving a frequency of about 2% and confirming the recurrence of this mutation. R1947X occurs within a CpG dinucleotide and supports the hypothesis that the mutation rate for this dinucleotide is higher than that of other dinucleotides. As routine analysis for R1947X is advisable, we have developed an allele-specific oligonucleotide hybridization assay for the efficient screening of a large number of samples.


Subject(s)
Genes, Neurofibromatosis 1 , Neurofibromatosis 1/genetics , Point Mutation , Alleles , Base Sequence , Dinucleoside Phosphates/genetics , Exons/genetics , Female , Genes, Dominant , Genetic Testing , Humans , Male , Molecular Sequence Data , Nucleic Acid Hybridization/genetics , Pedigree
10.
Hum Genet ; 94(4): 395-400, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7927336

ABSTRACT

The fragile X mental retardation syndrome is caused by an expansion of a trinucleotide repeat (CGG)n in the FMR-1 gene. Molecular genetic study of fragile X provides accurate diagnosis and facilitates genetic counseling in families with affected members. We present here the molecular study of 59 Spanish fragile X syndrome families using probe StB 12.3 and the polymerase chain reaction (PCR) of the (CGG)n repeat sequence of the FMR-1 gene. The results obtained have allowed us to characterize 455 individuals, including eight prenatal diagnoses. The clinical diagnosis of fragile X in 89 affected males was confirmed, 137 female carriers were identified (48 of whom were mentally retarded), 176 individuals "at risk" were found not to have the expansion, and 12 cases of normal transmitting males (NTM) were detected. In the sample studied, no de novo mutations were detected, nor any mutation different from that described for the (CGG)n expansion. One nonmentally retarded male was detected as having an unmethylated CpG island for the FMR-1 gene, but with more than 200 CGG repeats (high functioning male). The analysis of the (CGG)n repeat in 208 normal chromosomes gave an allele distribution similar to that in other Caucasoid population groups, with alleles of 29 and 30 CGG repeats accounting for 46% of the chromosomes. The combination of Southern analysis and PCR of the (CGG)n repeat is highly efficient for diagnosis, compared with cytogenetic techniques, especially in the detection of female carriers, NTMs, and prenatal diagnosis, enabling accurate genetic counseling to be provided in all cases.


Subject(s)
Fragile X Syndrome/genetics , Nerve Tissue Proteins/genetics , RNA-Binding Proteins , Repetitive Sequences, Nucleic Acid , Blotting, Southern , Female , Fragile X Mental Retardation Protein , Humans , Male , Pedigree , Polymerase Chain Reaction , Spain
11.
J Med Genet ; 31(8): 654-5, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7815428

ABSTRACT

We have used a non-isotopic PCR assay based on the chemiluminescent detection of blotted PCR products (CB-PCR) for two dynamic mutation diseases (Huntington's disease and spinocerebellar ataxia type 1). This gives an accurate sizing of alleles and permits a rapid analysis of at risk persons. The system involves PCR of the samples, separation of alleles on polyacrylamide gels, Southern blotting, and hybridisation with specific primers 3' labelled with fluorescein (F1)-dUTP as probes. CB-PCR retains the isotopic sensitivity for accurate allele determination, avoids isotopic manipulation, and provides the advantages of safety, long term storage of probes, and recycling of hybridisation solutions.


Subject(s)
Huntington Disease/genetics , Luminescent Measurements , Minisatellite Repeats , Polymerase Chain Reaction/methods , Spinocerebellar Degenerations/genetics , Alleles , Base Sequence , Blotting, Southern , Electrophoresis, Polyacrylamide Gel , Fluorescein-5-isothiocyanate , Humans , Molecular Sequence Data , Risk
12.
Am J Hum Genet ; 54(3): 437-42, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8116613

ABSTRACT

The fragile X phenotype has been found, in the majority of cases, to be due to the expansion of a CGG repeat in the 5'-UTR region of the FMR-1 gene, accompanied by methylation of the adjacent CpG island and inactivation of the FMR-1 gene. Although several important aspects of the genetics of fragile X have been resolved, it remains to be elucidated at which stage in development the transition from the premutation to the full mutation occurs. We present two families in which discordance between two sets of MZ twins illustrates two important genetic points. In one family, two affected MZ brothers differed in the number of CGG repeats, demonstrating in vivo mitotic instability of this CGG repeat and suggesting that the transition to the full mutation occurred postzygotically. In the second family, two MZ sisters had the same number of repeats, but only one was mentally retarded. When the methylation status of the FMR-1 CpG island was studied, we found that the majority of normal chromosomes had been inactivated in the affected twin, thus leading to the expression of the fragile X phenotype.


Subject(s)
Diseases in Twins/genetics , Fragile X Syndrome/genetics , Nerve Tissue Proteins/genetics , Repetitive Sequences, Nucleic Acid , Twins, Monozygotic , Adolescent , Adult , Base Sequence , Child , DNA Primers , Female , Fragile X Mental Retardation Protein , Humans , Male , Molecular Sequence Data , Mosaicism , Pedigree , RNA-Binding Proteins/genetics
13.
Prenat Diagn ; 14(2): 123-30, 1994 Feb.
Article in English | MEDLINE | ID: mdl-7910399

ABSTRACT

Duchenne and Becker muscular dystrophy (D/BMD) are usually problematical when trying to determine the carrier status of at-risk women, which usually has to be based on haplotype or dosage analysis on Southern blots. Using multiplex polymerase chain reaction (PCR) analysis, we have detected deletions in 20 out of 44 D/BMD families with living affected members (45.5 per cent), more often in sporadic cases of DMD (14/22 with detectable deletion) than in familial ones (4/15), the majority (15/20) occurring in the distal region of the D/BMD gene. Four highly informative short tandem repeat polymorphisms (STRPs), which lie within the distal deletion hot spot of the D/BMD gene, can show loss of heterozygosity in carrier females, providing direct evidence of their carrier status. These STRPs greatly improve informativity, with a combined heterozygosity of 100 per cent and with the majority of families informative for three of the four STRPs. In 14/15 (93 per cent) of the families with distal deletions, the STRPs provided direct information on carrier status, and in some cases, they provide valuable information on recombination breakpoints and non-paternity.


Subject(s)
Genetic Carrier Screening , Muscular Dystrophies/genetics , Polymorphism, Genetic , Adolescent , Dystrophin/genetics , Exons , Female , Gene Deletion , Genetic Linkage , Haplotypes , Humans , Male , Muscular Dystrophies/diagnosis , Pedigree , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Prenatal Diagnosis , Spain
14.
Genomics ; 10(2): 301-7, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1712752

ABSTRACT

The cystic fibrosis transmembrane conductance regulator is encoded by the gene known to be mutated in patients with cystic fibrosis. This paper reports the cloning and sequencing of cDNAs for the murine homolog of the human cystic fibrosis transmembrane conductance regulator gene. A clone that, by analogy to the human sequence, extends 3' from exon 9 to the poly(A) tail was isolated from a mouse lung cDNA library. cDNA clones containing exons 4 and 6b were also isolated and sequenced, but the remainder of the mRNA proved difficult to obtain by conventional cDNA library screening. Sequences spanning exons 1-9 were cloned by PCR from mouse RNA. The deduced mouse protein sequence is 78% identical to the human cystic fibrosis transmembrane regulator, with higher conservation in the transmembrane and nucleotide-binding domains. Amino acid sequences in which known cystic fibrosis missense mutations occur are conserved between man and mouse; in particular, the predicted mouse protein has a phenylalanine residue corresponding to that deleted in the most common human cystic fibrosis mutation (delta F508), which should allow the use of transgenic strategies to introduce this mutation in attempts to create a "cystic fibrosis mouse".


Subject(s)
Cystic Fibrosis/genetics , Membrane Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cloning, Molecular , Cystic Fibrosis Transmembrane Conductance Regulator , DNA , Gene Library , Humans , Mice , Molecular Sequence Data , Oligonucleotides/chemical synthesis , Polymerase Chain Reaction , Sequence Alignment
16.
Am J Hum Genet ; 42(1): 38-44, 1988 Jan.
Article in English | MEDLINE | ID: mdl-2892400

ABSTRACT

The genetic map in the region of human chromosome 7 that harbors the gene for cystic fibrosis (CF) has been refined by multilocus linkage studies in an expanded database including a large set of normal families. Six loci known to be linked to CF were examined: MET, an oncogene; COL1A2, collagen, TCRB, T-cell-receptor beta polypeptide; and three arbitrary loci--D7S8, D7S13, and D7S16--defined by probes pJ3.11, pB79a, and p7C22, respectively. The gene order with greatest statistical support is COL1A2-D7S13-D7S16-MET-D7S8-TCRB. Linkage analysis in families segregating for CF suggested that the most likely location of the CF gene on this map is between MET and D7S8.


Subject(s)
Chromosome Mapping , Chromosomes, Human, Pair 7 , Cystic Fibrosis/genetics , Genetic Linkage , Female , Genetic Markers , Humans , Male , Polymorphism, Restriction Fragment Length
17.
Nature ; 326(6116): 840-5, 1987.
Article in English | MEDLINE | ID: mdl-2883581

ABSTRACT

A genomic sequence close to the cystic fibrosis locus with the characteristics of an HTF island has been selectively cloned and characterized. Two markers flanking this sequence, which is conserved throughout mammalian evolution, show a very much greater disequilibrium than that found with any existing marker. A single mutational event accounts for most cases of cystic fibrosis. The sequence is expressed, and is a candidate for the cystic fibrosis gene.


Subject(s)
Blood Proteins/genetics , Chromosomes, Human, Pair 7/ultrastructure , Cystic Fibrosis/genetics , Genetic Markers , Polymorphism, Genetic , Polymorphism, Restriction Fragment Length , Animals , Base Sequence , Calgranulin A , Chromosome Mapping , Genetic Carrier Screening , Genetic Linkage , Humans , Hybrid Cells/ultrastructure , Methylation , Mice
19.
Prog Clin Biol Res ; 254: 181-90, 1987.
Article in English | MEDLINE | ID: mdl-2893385

ABSTRACT

The first linkage to CF was demonstrated to the enzyme paroxonase, a classical protein polymorphism, by the Copenhagen group. This was followed quickly by six cloned DNA sequences: pJ3.11, 7C22, COL1A2 and TCRB (St. Mary's), 917 (Toronto) and met (Salt Lake City). Both pJ3.11 and met are very close genetically to the CF mutation, and can be used for carrier detection and antenatal diagnosis in many informative families where there is a CF child. There is no evidence for heterogeneity of the CF locus. The collection of markers surrounding the CF locus is now sufficient to permit attempts to be made to isolate the defective gene using a combination of chromosome-mediated gene transfer, pulse field gel electrophoresis, NotI junction libraries, cosmid mapping and chromosome walking techniques.


Subject(s)
Cystic Fibrosis/genetics , Genetic Linkage , Genetic Markers , Chromosome Mapping , Humans , Molecular Biology , Polymorphism, Restriction Fragment Length
20.
Am J Hum Genet ; 39(6): 713-9, 1986 Dec.
Article in English | MEDLINE | ID: mdl-3467586

ABSTRACT

The linkage of cystic fibrosis (CF) and the polymorphic DNA markers pJ3.11, met, 7C22, DOCR1-917, COL1A2, and TCRB have jointly localized the mutation causing CF to chromosome 7q2.1-3.1. We report further linkage data with two polymorphic markers at the met oncogene locus, pmetH and pmetD, which supports the tight linkage found by White et al. between CF and met. One family shows evidence for meiotic recombination between CF and met. Analysis of haplotypes in CF pedigrees collected for linkage studies combined with data from single affected families requesting prenatal diagnosis (Farrall et al., Lancet i:1402-1404, 1986) shows CF and met to be in linkage equilibrium in our population while pJ3.11-CF haplotypes show a deviation from the equilibrium frequencies.


Subject(s)
Cystic Fibrosis/genetics , Genetic Linkage , Genetic Markers , Oncogenes , DNA/genetics , Female , Genotype , Humans , Male , Recombination, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...